Patent 10583298 was granted and assigned to Boston Scientific on March, 2020 by the United States Patent and Trademark Office.
The present disclosure pertains to methods, devices and systems for neurological regulation. The methods, devices and systems described herein are useful, for example, in the treatment of conditions of the bladder such as overactive bladder.